Yatırımcı.AI

BISTTRYNov 20, 18:19Live

Şok Marketler Ticaret A.Ş.

SOKM Price Target 2026Şok Marketler Ticaret A.Ş.

Star MarketRetail Trade
41.04−1.08 (−2.56%)
Volume
TRY 250M
Day range
40.52 – 41.68
Previous close
42.12
Market cap
TRY 24.3B

Last updated: Source: Borsa Istanbul, 15-minute delayed

The average price target of 10 brokers for SOKM is TRY 86.44 (November 9, 2026), implying 110.62% from the last price.

Broker price targets, buy-hold-sell ratings and model portfolio status for Şok Marketler Ticaret A.Ş. (SOKM). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.

Last updated: Source: Broker research

Analyst Consensus

Average target
86.44 TL
Median target
89.20 TL
Highest target
110.00 TL
Lowest target
51.80 TL
Upside
110.62%
Buy / Hold / Sell
9 / 1 / 0

Broker Price Targets

GedikGedikNovember 9, 2026Outperform97.00136.35%
HalkHalkNovember 6, 2026Buy88.40115.40%
DenizDenizNovember 6, 2026Buy74.0080.31%
İş Yatırımİş YatırımNovember 6, 2026Buy98.19139.25%
GarantiGarantiNovember 6, 2026Outperform80.0094.93%
Yapı KrediYapı KrediNovember 6, 2026Buy90.00119.30%
Ak YatirimAk YatirimNovember 6, 2026Outperform90.00119.30%
HSBCHSBCOctober 26, 2026Buy85.00107.12%
AtaAtaAugust 5, 2026Buy110.00168.03%
TeraTeraApril 15, 2026Market perform51.8026.22%
ICBCICBCJanuary 23, 2026Neutral70.00—
UnluUnluJanuary 12, 2026Buy82.00—
JP Morgan ChasebankJP Morgan ChasebankDecember 10, 2025Neutral77.00—

AI Fair Value

AI fair value
53.61 TL
Upside
30.63%
Model date
July 21, 2026
Analyst price targets for all stocks

Frequently Asked Questions

10 brokers have an average target of TRY 86.44 for SOKM, with 9 buy, 1 hold and 0 sell ratings.

The highest price target for SOKM is TRY 110.00, the lowest is TRY 51.80 and the median is TRY 89.20.

Our AI fair value model estimates TRY 53.61 for SOKM, a difference of 30.63% from the current price. The model was updated on July 21, 2026. Not investment advice.

No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.